Manuel Madrazo

563 total citations
20 papers, 204 citations indexed

About

Manuel Madrazo is a scholar working on Epidemiology, Rheumatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Manuel Madrazo has authored 20 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 5 papers in Rheumatology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Manuel Madrazo's work include Urinary Tract Infections Management (14 papers), Pelvic floor disorders treatments (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Manuel Madrazo is often cited by papers focused on Urinary Tract Infections Management (14 papers), Pelvic floor disorders treatments (5 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Manuel Madrazo collaborates with scholars based in Spain. Manuel Madrazo's co-authors include Arturo Artero, José Marı́a Eiros Bouza, Juan Alberola, José Miguel Nogueira, Ian López‐Cruz, Rafael Zaragoza, Anna Ferrer, Juan José Alegre Sancho, Francesc Puchades Gimeno and Federico V. Pallardó and has published in prestigious journals such as The American Journal of the Medical Sciences, Frontiers in Cellular and Infection Microbiology and BMC Infectious Diseases.

In The Last Decade

Manuel Madrazo

19 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Madrazo Spain 7 138 42 40 33 32 20 204
Aina Gomila‐Grange Spain 7 103 0.7× 26 0.6× 42 1.1× 32 1.0× 22 0.7× 17 210
Tanya Babich Israel 8 258 1.9× 75 1.8× 72 1.8× 39 1.2× 43 1.3× 20 315
Sina Helbig Germany 9 196 1.4× 72 1.7× 32 0.8× 48 1.5× 22 0.7× 20 306
Merel M. C. Lambregts Netherlands 10 151 1.1× 35 0.8× 28 0.7× 68 2.1× 98 3.1× 28 307
Т С Перепанова Russia 10 223 1.6× 71 1.7× 35 0.9× 14 0.4× 38 1.2× 24 284
Cordula Lebert Germany 8 208 1.5× 88 2.1× 35 0.9× 25 0.8× 24 0.8× 13 280
Eleanor Perrelli United States 5 262 1.9× 65 1.5× 17 0.4× 17 0.5× 36 1.1× 5 298
Verónica Rico Spain 8 49 0.4× 9 0.2× 19 0.5× 55 1.7× 9 0.3× 20 158
Gabriel Rebick Canada 5 130 0.9× 39 0.9× 4 0.1× 157 4.8× 57 1.8× 11 299
Lindsey Korbel United States 6 185 1.3× 144 3.4× 16 0.4× 24 0.7× 9 0.3× 7 306

Countries citing papers authored by Manuel Madrazo

Since Specialization
Citations

This map shows the geographic impact of Manuel Madrazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Madrazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Madrazo more than expected).

Fields of papers citing papers by Manuel Madrazo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Madrazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Madrazo. The network helps show where Manuel Madrazo may publish in the future.

Co-authorship network of co-authors of Manuel Madrazo

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Madrazo. A scholar is included among the top collaborators of Manuel Madrazo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Madrazo. Manuel Madrazo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López‐Cruz, Ian, et al.. (2025). Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers. Frontiers in Cellular and Infection Microbiology. 14. 1532417–1532417. 3 indexed citations
2.
Artero, Arturo, et al.. (2024). Recurrent Urinary Tract Infections in Older Adults Requiring Hospitalization in an Internal Medicine Ward. Microorganisms. 12(11). 2114–2114.
3.
Artero, Arturo, et al.. (2023). Influence of Sepsis on the Middle-Term Outcomes for Urinary Tract Infections in Elderly People. Microorganisms. 11(8). 1959–1959. 3 indexed citations
4.
Madrazo, Manuel, et al.. (2023). Risk Factors for Bacteremia and Its Clinical Impact on Complicated Community-Acquired Urinary Tract Infection. Microorganisms. 11(8). 1995–1995. 6 indexed citations
5.
Madrazo, Manuel, et al.. (2023). Risk Factors and the Impact of Multidrug-Resistant Bacteria on Community-Acquired Urinary Sepsis. Microorganisms. 11(5). 1278–1278. 2 indexed citations
6.
7.
Madrazo, Manuel, et al.. (2023). Lactate/albumin ratio prognostic value for mortality in patients older than 65 years with complicated urinary tract infection. Revista Clínica Española (English Edition). 223(6). 366–370. 2 indexed citations
8.
López‐Cruz, Ian, et al.. (2022). Sex differences in aged 80 and over hospitalized patients with community-acquired UTI: A prospective observational study. Heliyon. 8(10). e11131–e11131. 1 indexed citations
9.
Madrazo, Manuel, Ian López‐Cruz, Juan Alberola, et al.. (2022). Comparison of quick Pitt to quick sofa and sofa scores for scoring of severity for patients with urinary tract infection. Internal and Emergency Medicine. 17(5). 1321–1326. 5 indexed citations
10.
Madrazo, Manuel, Ian López‐Cruz, Rafael Zaragoza, et al.. (2021). Prognostic accuracy of Quick SOFA in older adults hospitalised with community acquired urinary tract infection. International Journal of Clinical Practice. 75(10). e14620–e14620. 6 indexed citations
11.
Madrazo, Manuel, et al.. (2021). Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection. BMC Infectious Diseases. 21(1). 1232–1232. 24 indexed citations
12.
Madrazo, Manuel, et al.. (2020). COVID‐19 in older adults: What are the differences with younger patients?. Geriatrics and gerontology international. 21(1). 60–65. 41 indexed citations
13.
Madrazo, Manuel, Juan Alberola, Anna Ferrer, et al.. (2019). Predictive factors for Enterococcus faecalis in complicated community‐acquired urinary tract infections in older patients. Geriatrics and gerontology international. 20(3). 183–186. 10 indexed citations
14.
Madrazo, Manuel, Juan Alberola, Ian López‐Cruz, et al.. (2019). Community‐onset Pseudomonas aeruginosa urinary sepsis in elderly people: Predictive factors, adequacy of empirical therapy and outcomes. International Journal of Clinical Practice. 73(12). e13425–e13425. 5 indexed citations
15.
Artero, Arturo, et al.. (2017). Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital. International Journal of Clinical Practice. 71(9). e13001–e13001. 16 indexed citations
16.
Madrazo, Manuel, et al.. (2016). Celulitis por Plesiomonas shigelloides en un pescador con lupus eritematoso sistémico. Enfermedades Infecciosas y Microbiología Clínica. 34(9). 605–606. 2 indexed citations
17.
Artero, Arturo, et al.. (2016). Effect of Bacteremia in Elderly Patients With Urinary Tract Infection. The American Journal of the Medical Sciences. 352(3). 267–271. 25 indexed citations
18.
López‐Cruz, Ian, et al.. (2016). Tratamiento con ertapenem de la neumonía que requiere ingreso en el hospital en el paciente anciano. Revista española de quimioterapia. Suplemento. 29(1). 8–14. 1 indexed citations
19.
Artero, Arturo, et al.. (2016). Ertapenem therapy for pneumonia requiring hospital admission in elderly people.. PubMed. 29(1). 8–14. 2 indexed citations
20.
Artero, Arturo, et al.. (2014). Influence of inadequate antimicrobial therapy on prognosis in elderly patients with severe urinary tract infections. European Journal of Internal Medicine. 25(6). 523–527. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aina Gomila‐Grange Breakdown of academic impact, for papers by Tanya Babich Breakdown of academic impact, for papers by Sina Helbig Breakdown of academic impact, for papers by Merel M. C. Lambregts Breakdown of academic impact, for papers by Т С Перепанова Breakdown of academic impact, for papers by Cordula Lebert Breakdown of academic impact, for papers by Eleanor Perrelli Breakdown of academic impact, for papers by Verónica Rico Breakdown of academic impact, for papers by Gabriel Rebick Breakdown of academic impact, for papers by Lindsey Korbel
Rankless by CCL
2026